NCT00023283View on ClinicalTrials.gov

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

February 29, 2004

Conditions

Heroin DependenceOpioid-Related DisordersSubstance Abuse, Intravenous

Interventions

DRUG

Buprenorphine

"1. Experimental Standard Medical Management with once-weekly medication dispensing~2. Experimental Standard Medical Management with thrice-weekly medication dispensing~3. Experimental Enhanced Medical Management with thrice-weekly medication dispensing"

Trial Locations (1)

06519

APT Residential Services Division, New Haven

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00023283 - Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 | Biotech Hunter | Biotech Hunter